• No results found

Crystal Engineering and Preliminary X- ray Studies on Ribonucleotide Reductase Large Subunit from Mycobacterium tuberculosis

N/A
N/A
Protected

Academic year: 2022

Share "Crystal Engineering and Preliminary X- ray Studies on Ribonucleotide Reductase Large Subunit from Mycobacterium tuberculosis"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Crystal Engineering and Preliminary X- ray Studies on Ribonucleotide Reductase Large Subunit from Mycobacterium

tuberculosis

Levon Chant Halabelian

Mycobacterium tuberculosis (Mtb) is a human pathogen that causes a well-known deadly disease called tuberculosis (TB). It is responsible for approximately 1.7 million human deaths each year.

There are more than 2 billion people in the world carrying the dormant pathogen inside their body, and 10% of those people will experience the active form of tuberculosis during their lifetime. The available treatment regimen is based on anti-tuberculosis drug therapy and lasts for six to nine months. The synergy between AIDS and tuberculosis, as well as the emergence of multi-drug resistant tuberculosis are considered a growing public health threat, which explains the urgent need for novel and more efficient anti-TB drugs in order to kill multi-drug resistant TB as well as to decrease to long treatment duration.

Ribonucleotide reductase (RNR) is considered a potential target for drug development because of its essential role in providing the necessary building blocks for copying the bacterial genetic code, which is crucial for its existence. The RNR enzyme consists of large (R1) and small (R2) subunits, and the binding of two subunits together is essential for generation of the biologically active form of the RNR enzyme. In order to design a new drug to inhibit the activity of RNR enzyme, we need to uncover the structure of the RNR enzyme to identify its binding sites and eventually to synthesize the desired inhibitory molecule. The aim of this research was to produce sufficient amount of soluble RNR enzyme and generate the crystals necessary for determination of the RNR R1 structure by X-ray crystallography techniques.

I managed to produce RNR R1 protein containing mutations at hydrophobic surface patches. The mutations had positive effects on its solubility and ability to crystallize. Large crystals were obtained at neutral pH and in the presence of PEG-4000. The generated crystals were taken to MAX lab in Lund for X-ray diffraction data collection. This data provides the fundamentals for further research in this field.

Degree Project in Applied Biotechnology, Master of Science (2 years), 2011 Examensarbete i tillämpad bioteknik 30 hp till masterexamen, 2011

Biology Education Center and Department of Cell and Molecular Biology, Uppsala University Supervisor: Prof. Torsten Unge

References

Related documents

Dessa pumpar kan antingen vara specifika för en viss antibiotika och då ge resistens för just den eller verka mer allmänt och då verka för resistens mot flera olika

tuberculosis imponerande sätt att förvärva resistens via mutationer, istället för via genöverföring, kan därför ses som fördelaktigt då denna framgångsrika bakterie

For rapid diagnosis of drug resistant TB, we have tested padlock probes that could detect the mutations associated with the anti- TB drugs resistance.. A padlock probe is a

Lane 1 represents SDS-PAGE analysis of RNR R1 protein after IMAC chromatography, and lane 2 represents SDS-PAGE analysis of RNR R1 protein after size exclusion chromatography.

The data demonstrate that spread of resistant TB strains, particu- larly of the Beijing lineage and its clusters 94–32 and 100–32, is an important root of the ongoing MDR-TB epidemic

Furthermore, the initial docking studies suggested that moving the P2 phenyl from the N-1 glycine residue to the R 6 position of the pyrazinone core would place the phenyl in

We were also able to obtain an X-ray struc- ture of this compound bound to MtGS, which showed that instead of forming a hydrogen bond to the backbone carbonyl oxygen of

tuberculosis phosphatidylinositol phosphate synthase (PgsA1, Rv2612c) is one such potential target; it is an integral plasma membrane en- zyme, belonging to the